Stockholm Stock Exchange | Mid Cap
Oncopeptides
+61.29%
Latest
-
3 months
CarnegieDNBABG Sundal CollierKempenDNB MarketsSEB Equities

Price Targets For Oncopeptides

AnalystPrice TargetDateUpside
Carnegie17 SEKSep -22
+61.29%
DNB28 SEKSep -22
ABG Sundal Collier12 SEKSep -22
Kempen35 SEKJul -22
DNB Markets40 SEKJun -22
SEB Equities0.35 SEKOct -21

About The Company

Oncopeptides AB is a Swedish pharmaceutical company that develops drugs for the treatment of cancer. It was founded in 2000, based on cancer research and supported by Healthcap, Industrifonden and Karolinska Institutet. Oncopeptode's shares have been listed on the Stockholm Stock Exchange's main list since 2017.
Wikipedia